Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Derhaschnig, U.
Right arrow Articles by Hirschl, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Derhaschnig, U.
Right arrow Articles by Hirschl, M. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2002) 17: 81-85
© 2002 European Renal Association-European Dialysis and Transplant Association

Microalbumin measurement alone or calculation of the albumin/creatinine ratio for the screening of hypertension patients?

Ulla Derhaschnig1, Harald Kittler2, Christian Woisetschläger1, Andreas Bur1, Harald Herkner1 and Michael M. Hirschl1,

1 Department of Emergency Medicine and 2 Clinic of Dermatology, University of Vienna, Vienna, Austria

Background. Spot urine sampling seems to be a reliable screening method for the detection of microalbuminuria in hypertensive patients. It remains unclear whether microalbumin measurement alone or calculation of the albumin/creatinine ratio (ACR) are more reliable for the detection of microalbuminuria in non-selected hypertensive patients.

Methods. Following collection of a spot, midstream urine sample, urine was collected for 24 h for the measurement of microalbumin in 264 hypertensive patients. We compared microalbumin concentration in the spot urine with microalbumin measured in the 24-h urine sample and examined the utility of the ACR in evaluating microalbuminuria in hypertensive patients. Pathologic microalbuminuria was assumed when the microalbumin concentration exceeded 30 mg/l in the 24-h urine sample. Diagnostic performance is expressed in terms of specificity, sensitivity, positive (PPV) and negative predictive value (NPV), and area under receiver operating characteristics curve (AUC).

Results. A total of 47 samples (17.8%) showed pathologic microalbuminuria in the 24-h urine sample. The diagnostic performance expressed as AUC was 0.94 (95% CI 0.90–0.98) for microalbumin measurement alone and 0.94 (95% CI 0.89–0.97) for ACR. The PPV and NPV were 44.2 and 97.9% for microalbumin measurement alone. ACR revealed a PPV of 29.3% and a NPV of 96.2% for males and 42.9 and 98% for females, if a cut-off value of 2.5 mg/mmol for males and of 4.0 mg/mmol for females was used.

Conclusions. The ACR did not provide any advantage compared with microalbumin measurement alone, but requires an additional determination of creatinine and the use of gender-specific cut-off values. Therefore, measurement of microalbuminuria alone in the spot urine sample is more convenient in daily clinical practice and should be used as the screening method for hypertensive patients.

Keywords: microalbuminuria; sensitivity; specificity; spot urine sampling

Correspondence and offprint requests to: Prof. Michael M. Hirschl, Department of Emergency Medicine, Waehringer Guertel 18–20, A-1090 Vienna, Austria. Email: michael.hirschl{at}akh\|[hyphen]\|wien.ac.at


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
S. Zhu, Y. Liu, L. Wang, and Q. H. Meng
Transforming growth factor-{beta}1 is associated with kidney damage in patients with essential hypertension: renoprotective effect of ACE inhibitor and/or angiotensin II receptor blocker
Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2841 - 2846.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
J. Danziger
Importance of Low-Grade Albuminuria
Mayo Clin. Proc., July 1, 2008; 83(7): 806 - 812.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
T. H. Jafar, N. Chaturvedi, J. Hatcher, and A. S. Levey
Use of albumin creatinine ratio and urine albumin concentration as a screening test for albuminuria in an Indo-Asian population
Nephrol. Dial. Transplant., August 1, 2007; 22(8): 2194 - 2200.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
A. R. Dyer, P. Greenland, P. Elliott, M. L. Daviglus, G. Claeys, H. Kesteloot, H. Ueshima, J. Stamler, and for the INTERMAP Research Group
Evaluation of Measures of Urinary Albumin Excretion in Epidemiologic Studies
Am. J. Epidemiol., December 1, 2004; 160(11): 1122 - 1131.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. von Eckardstein
Is there a need for novel cardiovascular risk factors?
Nephrol. Dial. Transplant., April 1, 2004; 19(4): 761 - 765.
[Full Text] [PDF]


Home page
HypertensionHome page
W. B. White, D. Duprez, R. St Hillaire, S. Krause, B. Roniker, J. Kuse-Hamilton, and M. A. Weber
Effects of the Selective Aldosterone Blocker Eplerenone Versus the Calcium Antagonist Amlodipine in Systolic Hypertension
Hypertension, May 1, 2003; 41(5): 1021 - 1026.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.